Mark Shearman - 13 Feb 2023 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
EVP, CHIEF SCIENTIFIC OFFICER
Signature
/s/ Mark Shearman
Issuer symbol
EDIT
Transactions as of
13 Feb 2023
Net transactions value
-$26,966
Form type
4
Filing time
15 Feb 2023, 15:30:45 UTC
Previous filing
16 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale $26,966 -2,790 -4.1% $9.67 65,559 13 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 19, 2021 and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 10, 2023. The sale does not represent a discretionary trade by the Reporting Person.